Emmaus Medical
  • CEO Letters
  • Overview
    • Mission
    • Leadership
      • Management Team
      • Board of Directors
    • Corporate Compliance
    • Corporate Governance
  • Products
    • Endari
  • Pipeline
    • Research Publications
    • Diverticulosis
    • Cell Sheet Engineering
  • News
    • Press Releases
    • Media Contacts
    • Media Kit
  • Investors
  • Career
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Pre-merger Emmaus Life Science SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Emmaus Life Sciences Reports 2024 Financial Results

Apr 14, 2025 6:25pm EDT

Emmaus Life Science Reports Grant of Endari Market Exclusivity In Kingdom of Saudi Arabia

Jan 29, 2025 9:30am EST

Emmaus Life Sciences Reports Improved Quarterly Financial Results

Nov 19, 2024 5:00pm EST

Emmaus Life Sciences Reports Quarterly Financial Results

Sep 10, 2024 2:15pm EDT

Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer

Jul 23, 2024 10:00am EDT

Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program

Jul 12, 2024 10:00am EDT

Emmaus Life Sciences Reports 2023 Financial Results

Jul 03, 2024 9:00am EDT

Emmaus Life Sciences Reports Delayed Filing of Annual Report

Apr 15, 2024 4:07pm EDT

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico

Feb 02, 2024 10:00am EST

Emmaus Life Sciences Reports Q3 2023 Financial Results

Nov 14, 2023 9:30am EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...17
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Emmaus Medical, Inc. Registered ® Emmaus Medical, Inc, Torrance, CA. All rights reserved.

  • Privacy
  • Terms of Use
  • Contact